Glenmark Pharma Q4 net soars 252%

According to a release issued by Glenmark to the BSE today, the group's Q4FY08 total income grew 70.5% to Rs 606.80 crore from Rs 355.93 crore in Q4FY07.

The group has posted 103.6% rise in FY08 consolidated net at Rs 631.26 crore when compared with Rs 310.06 crore reported in FY07. Total income has increased 64.2% to Rs 2,022.90 crore from Rs 1,232.22 crore.